Additionally, the in-vitro scratch assay demonstrated that silencing of NEP augmented cell proliferation, whereas the upregulation of NEP using the HDAC1 inhibitors resulted in decreased cancer proliferation. The gene discussed is HDAC1; the disease is cancer.